8-K 1 d8k.htm FORM 8-K - AMERISOURCEBERGEN CORP Form 8-K - AmerisourceBergen Corp

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report (Date of earliest event reported): April 23, 2008

AmerisourceBergen Corporation

(Exact name of Registrant as specified in its charter)

 

Delaware   1-16671   23-3079390

(State or Other Jurisdiction of

Incorporation or Organization)

  Commission File Number  

(I.R.S. Employer

Identification Number)

 

 

 

1300 Morris Drive

Chesterbrook, PA

  19087
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (610) 727-7000

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02. Results of Operations and Financial Condition.

On April 23, 2008, AmerisourceBergen Corporation (the “Registrant”) issued a news release announcing its earnings for the fiscal quarter ended March 31, 2008 and announcing its corresponding earnings conference call. A copy of the news release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

Item 8.01. Other Events.

In the news release issued on April 23, 2008, the Registrant announced that it was discontinuing the sale process for PMSI, its workers’ compensation business. The Registrant also announced that it was narrowing its expectations for fiscal year 2008 diluted earnings per share to a range of $2.77 to $2.87 from the previous range of $2.77 to $2.95, due primarily to the expected weaker performance of PMSI, as well as the impact from lower sales of anemia drugs in the Specialty Group and the slowing growth of the overall pharmaceutical market. A copy of the news release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

99.1 News Release, dated April 23, 2008, regarding Registrant’s earnings for the fiscal quarter ended March 31, 2008 and other matters.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    AMERISOURCEBERGEN CORPORATION
Date: April 23, 2008     By:  

/s/ Michael D. DiCandilo

    Name:   Michael D. DiCandilo
    Title:  

Executive Vice President

and Chief Financial Officer